Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Asking better questions to inform a stronger strategy

Pausing to question the data being used to inform decisions is invaluable in creating better strategy

- PMLiVE

Walking in their shoes

The impact of experiencing what it would be like to have a chronic disease for a day

- PMLiVE

Will that be cash or charge?

India is asking people to pay for booster shots, but extremely poor countries should never consider charging people for public health services

- PMLiVE

EFPIA-EURORDIS joint statement published on patient access to medicines for rare diseases

The statement contains a series of proposals to improve the lives of people living with rare diseases by addressing access barriers to transformative medicines

- PMLiVE

NHS England launches pilot programme for high street pharmacy referrals

The scheme aims to diagnose more early stage cancers without the need for a GP appointment

- PMLiVE

EU governments pressure manufacturers to renegotiate contracts for COVID-19 vaccines

EU officials have warned that millions of vaccine doses could be wasted due to over-supply

Embrace mental health first aiders for better work wellbeing

Mental health first aid can work as a vital steppingstone to instilling good mental health practices into wider company culture and ensure everyone knows what to be looking out for...

Page & Page Health

- PMLiVE

Behaviour change – a maze of decisions influenced by personal habits, experiences and intentions

By Danny Buckland

- PMLiVE

How COVID-19 has renewed the focus on behaviour change

By Rachel Rowson

- PMLiVE

Making the case for embedding personalised healthcare in secondary care – what can pharma do to help?

By Doina Ionescu

- PMLiVE

Celebrating World Blood Donor Day

Each 14th June World Blood Donor day is celebrated around the world to spread awareness around the importance of giving blood.

Innovative Trials

- PMLiVE

Eli Lilly and Incyte’s Olumiant receives FDA approval for alopecia

The treatment is the first and only systemic medicine for adults with the condition

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links